Repair Biotechnologies
PrivateLast Round
Seed
Nov 25, 2025
Est. Valuation
$74.42M
Total Funding Raised
$36.18M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Repair Biotechnologies operates in Healthcare & Life Sciences and is based in Syracuse, New York. Its latest recorded funding round was a Seed round in November 2025.
Repair Biotechnologies is a biotechnology company developing therapies that target and reduce cholesterol levels using a proprietary Cholesterol Degrading Platform (CDP) to address medical conditions caused by excess cholesterol accumulation, such as atherosclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Repair Biotechnologies Comparables
Compare Repair Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclarity Therapeutics | 81% | |
| Elastrin Therapeutics | 76% | |
| Bitterroot Bio | 75% |
For institutional investors. Book with your work email.
Repair Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 25, 2025 | ||||
| Series A Extension | Mar 26, 2024 | ||||
| Series A | Jun 16, 2023 | ||||
| SAFE | May 27, 2022 | ||||
| Pre Seed | Feb 23, 2021 | ||||
Seed | Sep 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Repair Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grapeseed | SAFE |
| Bioverge | SAFE, Series A, Seed |
| Longevitytech.fund | SAFE, Series A |
| VitaDAO | SAFE |
| Thynk Capital | SAFE, Series A, Seed |
| Healthspan Capital | SAFE, Seed, Series A |
| SENS Research Foundation | SAFE, Pre Seed, Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 53% MoM.
- Nov 25, 2025
Raised $11.4M from 100 Plus Capital, Bioverge, and Healthspan Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 2, 2026
Repair Biotechnologies, Inc. is selected to participate as a Pitch finalist in the RESI Boston 2026 Innovator's Pitch Challenge in Massachusetts, held Sep 22nd–23rd '26.
- attends_eventSep 2, 2026
Repair Biotechnologies, Inc. is selected to participate in the RESI Boston 2026 Innovator's Pitch Challenge in Massachusetts on Sep 22nd–23rd '26.
For institutional investors. Book with your work email.
Repair Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Repair Biotechnologies's valuation, stock price, and market status.
Is Repair Biotechnologies a public or private company?
Repair Biotechnologies is a private company.
What is the current stock price of Repair Biotechnologies?
Repair Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Repair Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Repair Biotechnologies worth (valuation)?
Repair Biotechnologies's valuation is estimated at $74.4M based on funding round data.
Can I buy Repair Biotechnologies stock?
Repair Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Repair Biotechnologies's last funding round?
Repair Biotechnologies's most recent funding round was Seed on November 25, 2025.
Who are the main investors in Repair Biotechnologies?
Key investors in Repair Biotechnologies include Healthspan Capital.
Will Repair Biotechnologies IPO soon?
No public IPO plans have been announced for Repair Biotechnologies.
How can I track Repair Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Repair Biotechnologies's shares on secondary markets.